[Improved Protective Equipment for NICU Portable Radiography].

We have been developing protective equipment for portable radiography in neonatal intensive care units because the portable radiography's X-ray tube is in close proximity to the head of the nurse who is assisting the patient. Although our initial protective-equipment design was highly effective, there were some concerns that it obstructed the view of the patient and was difficult to handle. To overcome this problem, we have developed two new types of protective device: a narrow-type 0.13 mmPb device, 17 cm long and 45 cm wide (weight 200 g); and a wide type with a wider core material, 45 cm long and 25 cm wide (weight 300 g), both of which can be hung from the collimator cover of mobile X-ray equipment. The measured protective effectiveness was 80.6% at head height for the wide type and 76.8% for the narrow type. A survey of nurses regarding the new protective devices revealed no significant differences between the two types in terms of visibility and whether the devices would be an obstacle when assisting patients. The nurses preferred the wider type, which offered better protection. Radiological technologists also liked that both types were easy to handle because the irradiation field could be adjusted even after the device was fitted. Both types of the new protective device are thus expected to be useful in clinical practice in terms of their high protective effect and improved ease of handling.

[Creation of Protective Equipment for Portable Radiography in Neonatal Intensive Care Unit].

Portable imaging in the NICU requires the assistance of a nurse, and the nurse is in close proximity to the X-ray tube, In all, 64 percent of our nurses thought that additional protective equipment was needed. Therefore, a radiation protection device was created and its usefulness was verified. A protective equipment of 0.13 mmPb with a width of 38 cm and a length of 70 cm was made and hung from the mono-tank X-ray unit of the mobile X-ray unit. The position of the nurse was set at 30 cm outward from the center of the irradiation field, and the protective effect was measured at three points: (a) the patient's height, (b) 30 cm above the patient, and (c) 60 cm above the patient. For the imaging conditions, a 2-liter plastic bottle filled with water was placed in the incubator, and measurements were taken with an SID of 100 cm, irradiated field of 20.3 cm×25.4 cm, tube voltage of 58 kV, and tube current-time product of 10 mAs, which was converted to the actual imaging condition of 1 mAs. Based on the results obtained, a questionnaire survey was conducted on nurses' thoughts for the protective equipment created for them. Only 3% reduction in height of (a) where no protective equipment is reached but (b) 50% and (c) 92%, respectively. In all, 82 percent of the nurses had a favorable impression of the new protective equipment. It is expected that the protective equipment designed to control lens dose and reduce anxiety of nurses will be useful.

Development of a remote-control system for catheterization capable of high-speed force feedback.

PURPOSE: There is a growing interest in minimally invasive surgery as interventional radiology (IVR), which decreases the burden on a patient. However, occupational exposure is a problem because the treatment is performed using X-ray fluoroscopic images. This problem can be solved by the development of a teleoperation system, but rapid force presentation is important to perform safe surgery. The purpose of this study is to develop a new teleoperation system that can be controlled at a high speed and can provide feedback force sensation within 20 ms delay. METHODS: A master-slave-type remote-control system for catheterization was developed. A compact and high-speed force feedback system is realized using a novel electro-attractive material (EAM) device by which the resistance force is generated by the magnitude of the voltage applied. The linear and rotational movement of master is transferred to the slave device by UDP communication with the LAN cable, and the same movement is performed by two motors. The collision force of catheter or guidewire, detected by the sensor inside the slave device, is also transmitted to the master device. Two voltage-based methods for EAM: the ON/OFF and linear control methods, were implemented. RESULTS: After the collision force is detected by the slave sensor, the voltage is applied to the EAM in the master device for an average of 10.33 ms and 15.64 ms by the ON/OFF and linear control methods, respectively. These delays are less than required 20 ms. The movement of the master was stopped by the resistance force of EAM, and that of the slave was also stopped accordingly. CONCLUSION: A master-slave-type remote-control system for catheterization that is capable of high-speed force feedback was developed. With a low delay, the developed system achieved the requirements of 20 ms that was aimed for this study. Therefore, this system may facilitate the realization of IVR surgery that is safe for both doctors and patients.

Use of antithrombin and thrombomodulin in the management of disseminated intravascular coagulation in patients with acute cholangitis.

BACKGROUND/AIMS: To evaluate the usefulness and safety of treating disseminated intravascular coagulation (DIC) complicating cholangitis primarily with antithrombin (AT) and thrombomodulin (rTM). METHODS: A DIC treatment algorithm was determined on the basis of plasma AT III levels at the time of DIC diagnosis and DIC score changes on treatment day 3. Laboratory data and DIC scores were assessed prospectively at 2-day intervals. RESULTS: DIC reversal rates >75% were attained on day 7. In the DIC reversal group, statistically significant differences from baseline were observed in interleukin-6 and C-reactive protein levels within 5 days. Patients with no DIC score improvements after treatment with AT alone experienced slow improvement on a subsequent combination therapy with rTM. Although a subgroup with biliary drainage showed greater improvement in DIC scores than did the nondrainage subgroup, the mean DIC score showed improvement even in the nondrainage subgroup alone. Gastric cancer bleeding that was treated conservatively occurred in one patient. As for day 28 outcomes, three patients died from concurrent malignancies. CONCLUSIONS: Although this algorithm was found to be useful and safe for DIC patients with cholangitis, it may be better to administer rTM and AT simultaneously from day 1 if the plasma AT III level is less than 70%.

Xenon computed tomography can evaluate the improvement of hepatic hemodynamics before and after endoscopic injection sclerotherapy.

BACKGROUND: Xenon computed tomography (Xe-CT) provides quantitative information on tissue blood flow (TBF). In the present study, Xe-CT was performed in patients with esophagogastric varices (EGV) before and after endoscopic injection sclerotherapy (EIS) to evaluate hepatic blood flow (HBF), hepatic arterial TBF (HATBF) and portal venous TBF (PVTBF). METHODS: Subjects comprised of 88 patients with EGV (49 men, 39 women, average age 65.8 ± 11.5 years, median age 68 years, 30-86 years) and liver cirrhosis related to either hepatitis C virus (C) (n = 33), hepatitis B virus (B) (n = 3), alcohol (AL) (n = 22), AL + C (n = 7), AL + B (n = 1), B + C + AL (n = 1), nonalcoholic steatohepatitis (NASH) (n = 4), autoimmune hepatitis (AIH) (n = 5), primary biliary cirrhosis (PBC) (n = 2), or cryptogenic (n = 10) were enrolled. All patients, who were enrolled in this study, were performed EIS for prophylaxis. Xe-CT and measurement of the retention rate of indocyanine green 15 min after administration (ICG R15) were performed before and after EIS. Total hepatic TBF (THTBF) and PVTBF/HATBF ratio (P/A) were also calculated. RESULTS: PVTBF, HATBF, THTBF, P/A and ICG R15 before EIS were 28.3 ± 8.91, 22.5 ± 14.4 and 50.8 ± 17.6 ml/100 ml/min, 1.62 ± 0.71 and 28.8 ± 12.7 %, respectively and those after EIS were 31.9 ± 10.0, 19.3 ± 11.6, and 51.2 ± 17.0 ml/100 ml/min, 1.92 ± 0.84 and 23.6 ± 11.3 %, respectively. PVTBF and P/A after EIS were significantly higher than those before EIS (p = 0.00444, p = 0.0179, respectively), and HATBF and ICG R15 after EIS were significantly lower than those before EIS (p = 0.00129, p < 0.001, respectively). CONCLUSIONS: Xenon computed tomography showed that PVTBF increased after EIS for EGV and HATBF decreased in response to an increase in PVTBF.

[Gemcitabine therapy for unresectable pancreatic cancer in elderly patients].

We evaluated the therapeutic effect of gemcitabine (GEM) therapy in 153 unresectable pancreatic cancer (UPC) patients, divided into younger patients (under 65), early-stage elderly patients (age 65-74) and advanced-stage elderly patients (age 75 and over). Among those patients who received only best supportive care (BSC), the most common reasons to be selected for BSC were family requests in the advanced-stage elderly patients, and poor general condition in the rest. Among the patients who received GEM therapy, there were no significant differences in response rate, or adverse events including the rate of dose reduction, postponement or cessation of GEM administration due to toxicity. Multivariate analysis using patient backgrounds and response to GEM therapy showed that CA 19-9 response and performance status did not change with age. GEM therapy for both early-stage and advanced-stage elderly UPC patients was as safe and useful as in younger patients.